Chelated Oral Iron Versus Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia Late in Pregnancy

Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexFemale
Age18+
SponsorAssiut University

About this trial

compare the efficacy and safety of intravenous iron sucrose versus chelated oral iron in the treatment of iron deficiency anemia late in pregnancy.

Eligibility criteria

Qualifiers

Women aged 18 years or more with established iron deficiency anemia ( Hb: 8-10 )

Pregnancy 26-34 weeks

Disqualifiers

Anemia due to other causes than iron deficiency anemia.

Recent blood transfusion (in the last 3 months ).

Allergy to iron.

Multiple pregnancy.

Trial design

Treatments tested in this trial

  • Chelated Iron
  • Iron sucrose

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators